Replies to post #114742 on Biotech Values

[zipjet]

Hi j,

First, he isn't aware that the .5 copaxone has been kicked back by the fda or maybe his concern was the 3x dosing trial that'll possibly be done before M-Copax approval.

Are you sure?

...should Teva be able to launch ...

I do not read it that way.

ij

[DewDiligence]

…maybe his concern was the 3x dosing trial that'll possibly be done before M-Copax approval.

For that to happen, generic Copaxone would have to still be unapproved five years from now (#msg-59789214). Possible but not likely, IMO.